First Endurance Welcomes Dr Luke Bucci, PhD, As Chief Scientific Officer

July 15, 2020 - /PressAdvantage/ - First Endurance announced and welcomed Luke Bucci, PhD, CCN, CN, as Chief Scientific Officer in charge of developing and publishing new clinical trials on endurance athletes and developing new patentable formulas for upcoming products.

With over thirty years of experience, Dr. Bucci is widely regarded as the industry leader in sports nutrition. His scientific writings have been published in books, peer-reviewed research articles, and technical journals. He holds multiple patents for nutritional breakthroughs and has served as an expert advisor on the United States Olympic Committee.

The First Endurance founder and CEO Michael Fogarty expressed his excitement with Dr. Bucci joining the team, saying: “I’ve known Dr. Bucci for over two decades and always considered him to be the foremost authority on sports nutrition. I couldn't imagine having anyone other than Luke Bucci help us take another big leap forward."

Dr. Bucci's nutritional innovations have had a significant impact on industry growth. His product introductions propelled one company to 15x sales growth, resulting in $300 million in annual sales. He is also responsible for building new categories such as joint health, and developing the top-selling products in these markets.

Not wasting any time, Dr. Bucci has already developed new prototype formulas and has been receiving exceptional feedback from early testers in First Endurance's team of sponsored athletes.

“I am excited to jump into sports nutrition at the highest level with First Endurance,” says Bucci. He added, "There are so many ways to improve performance beyond carbs and caffeine that are not available on the market. We’re going to change that.”

More details can be found at https://firstendurance.com/dr-luke-bucci-chief-scientific-officer/.

###

For more information about First Endurance, contact the company here:

First Endurance
Mike Fogarty
1 (866)-347-7811
[email protected]
P.O. Box 71661, Salt Lake City, UT 84171

ReleaseID: 60037133